Gilaburu extract (Viburnum opulus Linnaeus) is as effective as Tamsulosin in medical expulsive therapy of distal ureteral calculi.
Journal
International journal of clinical practice
ISSN: 1742-1241
Titre abrégé: Int J Clin Pract
Pays: India
ID NLM: 9712381
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
revised:
23
08
2021
received:
16
06
2021
accepted:
02
10
2021
pubmed:
6
10
2021
medline:
1
1
2022
entrez:
5
10
2021
Statut:
ppublish
Résumé
To compare the extract of Gilaburu (Viburnum opulus Linnaeus) and Tamsulosin as a medical expulsive therapy (MET) in patients with distal ureteral calculi of 10 mm or less. Data of 86 patients were prospectively collected. The patients were divided into two groups. In the first group, Viburnum opulus 1000 mg peroral 3 × 2 and diclofenac 50 mg peroral on-demand (n = 43), in the second group Tamsulosin 0.4 mg peroral 1 × 1 and diclofenac 50 mg peroral on-demand (n = 43) was given for MET in patients with distal ureteral calculi. Stone expulsion rates, time until expulsion, additional analgesic requirement, need for emergency admission, need for additional treatment were evaluated. In addition, subgroup analyses of ≤5 and 5-10 mm were also performed. There was no difference between the groups in terms of stone expulsion rates and time until the expulsion in all stones. Additional analgesic requirement and need for emergency admission were found to be lower in the Viburnum opulus group (37.2% vs 65.1%, P = .017 and 11.6% vs 34.8%, P = .02, respectively). In subgroup analyses, while stone expulsion rates were similar in subgroups, it was found shorter in the time until expulsion, lower additional analgesic requirement and need for emergency admission in V. opulus group than Tamsulosin group in 5-10 mm stone size subgroup (7.1 ± 4.2 vs 11.8 ± 5.2, P = .005, 32.2% vs 77.7%, P = .001 and 12.9% vs 40.7%, respectively). V. opulus can be used effectively and safely for the treatment of MET in distal ureteral calculi.
Sections du résumé
BACKGROUND
BACKGROUND
To compare the extract of Gilaburu (Viburnum opulus Linnaeus) and Tamsulosin as a medical expulsive therapy (MET) in patients with distal ureteral calculi of 10 mm or less.
METHODS
METHODS
Data of 86 patients were prospectively collected. The patients were divided into two groups. In the first group, Viburnum opulus 1000 mg peroral 3 × 2 and diclofenac 50 mg peroral on-demand (n = 43), in the second group Tamsulosin 0.4 mg peroral 1 × 1 and diclofenac 50 mg peroral on-demand (n = 43) was given for MET in patients with distal ureteral calculi. Stone expulsion rates, time until expulsion, additional analgesic requirement, need for emergency admission, need for additional treatment were evaluated. In addition, subgroup analyses of ≤5 and 5-10 mm were also performed.
RESULTS
RESULTS
There was no difference between the groups in terms of stone expulsion rates and time until the expulsion in all stones. Additional analgesic requirement and need for emergency admission were found to be lower in the Viburnum opulus group (37.2% vs 65.1%, P = .017 and 11.6% vs 34.8%, P = .02, respectively). In subgroup analyses, while stone expulsion rates were similar in subgroups, it was found shorter in the time until expulsion, lower additional analgesic requirement and need for emergency admission in V. opulus group than Tamsulosin group in 5-10 mm stone size subgroup (7.1 ± 4.2 vs 11.8 ± 5.2, P = .005, 32.2% vs 77.7%, P = .001 and 12.9% vs 40.7%, respectively).
CONCLUSION
CONCLUSIONS
V. opulus can be used effectively and safely for the treatment of MET in distal ureteral calculi.
Substances chimiques
Plant Extracts
0
Sulfonamides
0
Tamsulosin
G3P28OML5I
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14950Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Scales CD, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62:160-165.
Pak CY. Kidney stones. Lancet. 1998;351:1797-1801.
Sagdic O, Ozturk I, Yapar N, Yetim H. Diversity and probiotic potentials of lactic acid bacteria isolated from crampbark, a traditional Turkish fermented European cranberrybush (Viburnum opulus L.) fruit drink. Food Res Int. 2014;64:537-545.
Erturhan S, Erbagci A, Yagci F, Celik M, Solakhan M, Sarica K. Comparative evaluation of efficacy of use of Tamsulosin and/or tolterodine for medical treatment of distal ureteral stones. Urology. 2007;69:633-636.
Preminger GM, Tiselius H-G, Assimos DG, et al. 2007 guideline for the management of ureteral calculi. J Urol. 2007;178:2418-2434.
de Bessa J, Reggio E, Mendes GC. Back to the future: medical expulsive therapy for large distal stones. Ann Emerg Med. 2019;73:312-313.
Solakhan M, Bayrak O, Bulut E. Efficacy of mirabegron in medical expulsive therapy. Urolithiasis. 2019;47:303-307.
Davenport K, Timoney AG, Keeley FX. Effect of smooth muscle relaxant drugs on proximal human ureteric activity in vivo: a pilot study. Urol Res. 2007;35:207-213.
Kraujalytė V, Venskutonis PR, Pukalskas A, Česonienė L, Daubaras R. Antioxidant properties and polyphenolic compositions of fruits from different European cranberrybush (Viburnum opulus L.) genotypes. Food Chem. 2013;141:3695-3702.
Kajszczak D, Zakłos-Szyda M, Podsędek A. Viburnum opulus L.-a review of phytochemistry and biological effects. Nutrients. 2020;12:3398.
Kızılay F, Ülker V, Çelik O, et al. The evaluation of the effectiveness of Crampbark (Viburnum opulus L.) extract in the medical expulsive treatment of distal ureteral stones. Turk J Urol. 2019;45(Supp. 1):S63-S69.
Ilhan M, Ergene B, Süntar I, et al. Preclinical evaluation of antiurolithiatic activity of Viburnum opulus L. on sodium oxalate-induced urolithiasis rat model. Evid Based Complement Alternat Med. 2014;2014:578103.
Altun ML, Saltan Çitoğlu G, Sever Yılmaz B, Özbek H. Antinociceptive and anti-inflammatory activities of Viburnum opulus. Pharm Biol. 2009;47:653-658.
Dellabella M, Milanese G, Muzzonigro G. Efficacy of Tamsulosin in the medical management of juxtavesical ureteral stones. J Urol. 2003;170:2202-2205.
Theriault B, Morin F, Cloutier J. Safety and efficacy of Tamsulosin as medical expulsive therapy in pregnancy. World J Urol. 2020;38:2301-2306.
Hermanns T, Sauermann P, Rufibach K, Frauenfelder T, Sulser T, Strebel RT. Is there a role for Tamsulosin in the treatment of distal ureteral stones of 7 mm or less? Results of a randomised, double-blind, placebo-controlled trial. Eur Urol. 2009;56:407-412.
Vincendeau S, Bellissant E, Houlgatte A, et al. Tamsulosin hydrochloride vs placebo for management of distal ureteral stones: a multicentric, randomized, double-blind trial. Arch Intern Med. 2010;170:2021-2027.
Pickard R, Starr K, MacLennan G, et al. Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicenter, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (Tamsulosin) (the SUSPEND trial). Health Technol Assess. 2015;19(63):1-72, 1-171.
Portis AJ, Portis JL, Borofsky MS, Neises SM. Beyond medical expulsive therapy: evolution to supported stone passage for ureteric stones. BJU Int. 2019;123:661-668.
Furyk JS, Chu K, Banks C, et al. Distal ureteric stones and tamsulosin: a double-blind, placebo-controlled, randomized, multicenter trial. Ann Emerg Med. 2016;67:86-95.e2.
Ye Z, Zeng G, Yang H, et al. Efficacy and safety of Tamsulosin in medical expulsive therapy for distal ureteral stones with renal colic: a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol. 2018;73:385-391.
Meltzer AC, Burrows PK, Wolfson AB, et al. Effect of Tamsulosin on passage of symptomatic ureteral stones: a randomized clinical trial. JAMA Intern Med. 2018;178:1051-1057.
Tao R-Z, Qin Z-Q, Liu F, Lv J-L. Efficacy and safety of Tamsulosin in the medical expulsion therapy for distal ureteral calculi: a systematic review and meta-analysis of placebo-controlled trials. Urol J. 2019;16:224-231.
Campschroer T, Zhu X, Vernooij RWM, Lock TMTW. α-blockers as medical expulsive therapy for ureteric stones: a Cochrane systematic review. BJU Int. 2018;122:932-945.
Sridharan K, Sivaramakrishnan G. Efficacy and safety of alpha-blockers in medical expulsive therapy for ureteral stones: a mixed treatment network meta-analysis and trial sequential analysis of randomized controlled clinical trials. Expert Rev Clin Pharmacol. 2018;11:291-307.
Hsu Y-P, Hsu C-W, Bai C-H, Cheng S-W, Chen K-C, Chen C. Silodosin versus Tamsulosin for medical expulsive treatment of ureteral stones: a systematic review and meta-analysis. PLoS One. 2018;13:e0203035.
Sridharan K, Sivaramakrishnan G. Medical expulsive therapy in urolithiasis: a mixed treatment comparison network meta-analysis of randomized controlled clinical trials. Expert Opin Pharmacother. 2017;18:1421-1431.
Gnyawali D, Pradhan MM, Sigdel PR, et al. Efficacy of Tamsulosin plus Tadalafil versus Tamsulosin as medical expulsive therapy for lower ureteric stones: a randomized controlled trial. Adv Urol. 2020;2020:4347598.